“Great Therapies for All-Comers” in CLL: How Can Oncologists “Pick and Choose?”
Manage episode 407462003 series 3560609
As treatment options increase for patients with CLL, so do questions about which interventions, if any, are right for which patients and when. Bob Figlin, MD, and Nicole Lamanna, MD, discuss key considerations, ranging from cardiac toxicity to why Dr. Lamanna “won't just treat for a symptom.”
120 episodes